Alliance Pharma (LON:APH) Reaches New 52-Week High – Should You Buy?

Alliance Pharma plc (LON:APH) shares reached a new 52-week high during trading on Thursday . The stock traded as high as GBX 61.60 ($0.77) and last traded at GBX 61.40 ($0.77), with a volume of 519622 shares. The stock had previously closed at GBX 61.20 ($0.77).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank cut Alliance Pharma to a “hold” rating and lowered their target price for the stock from GBX 7,000 ($87.51) to GBX 6,250 ($78.13) in a report on Wednesday, January 29th.

Alliance Pharma Stock Up 0.3 %

The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 47.46. The firm has a market cap of £331.91 million, a PE ratio of -1,023.33, a P/E/G ratio of 1.04 and a beta of 0.67. The business’s 50-day simple moving average is GBX 51.89 and its 200 day simple moving average is GBX 45.13.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.